- Home
- PRPH vs XAIR Comparison
PRPH vs XAIR Comparison
Compare PRPH & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- XAIR
- Stock Information
- Founded
- PRPH 1989
- XAIR 2011
- Country
- PRPH United States
- XAIR United States
- Employees
- PRPH N/A
- XAIR N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- XAIR Medical/Dental Instruments
- Sector
- PRPH Health Care
- XAIR Health Care
- Exchange
- PRPH Nasdaq
- XAIR Nasdaq
- Market Cap
- PRPH 15.2M
- XAIR 17.0M
- IPO Year
- PRPH 1997
- XAIR N/A
- Fundamental
- Price
- PRPH $0.36
- XAIR $3.23
- Analyst Decision
- PRPH
- XAIR Strong Buy
- Analyst Count
- PRPH 0
- XAIR 3
- Target Price
- PRPH N/A
- XAIR $23.67
- AVG Volume (30 Days)
- PRPH 813.9K
- XAIR 174.7K
- Earning Date
- PRPH 08-13-2025
- XAIR 08-05-2025
- Dividend Yield
- PRPH N/A
- XAIR N/A
- EPS Growth
- PRPH N/A
- XAIR N/A
- EPS
- PRPH N/A
- XAIR N/A
- Revenue
- PRPH $5,845,000.00
- XAIR $3,705,000.00
- Revenue This Year
- PRPH $221.82
- XAIR $266.61
- Revenue Next Year
- PRPH N/A
- XAIR $140.76
- P/E Ratio
- PRPH N/A
- XAIR N/A
- Revenue Growth
- PRPH N/A
- XAIR 219.67
- 52 Week Low
- PRPH $0.22
- XAIR $2.90
- 52 Week High
- PRPH $3.37
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- PRPH 46.36
- XAIR 43.87
- Support Level
- PRPH $0.35
- XAIR $2.90
- Resistance Level
- PRPH $0.46
- XAIR $3.38
- Average True Range (ATR)
- PRPH 0.03
- XAIR 0.32
- MACD
- PRPH -0.01
- XAIR -0.05
- Stochastic Oscillator
- PRPH 19.36
- XAIR 25.71
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.